糖尿病監測設備市場：按產品類型、適應症、最終用戶和地區分類

Diabetes Monitoring Devices Market, By Product Type, By Indication, By End User, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，糖尿病監測設備市場規模將達到146.6億美元，2033年將達到261.2億美元。預計從2026年到2033年，該市場將以8.6%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	146.6億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	8.60%	2033年市場規模預測：	261.2億美元

血糖值儀是糖尿病患者和醫護人員用來監測和管理患者血糖值的工具。大多數患者在非住院環境下使用這些設備。這些患者中許多是老年人，行動不便，視力也可能受損。血糖值儀有一個測量端口，患者將塗有血液的小型校準試紙插入其中進行分析。為了方便行動不便的使用者使用，試紙的尺寸不應過小或難以操作。

市場動態

全球糖尿病盛行率的不斷上升是推動糖尿病監測設備市場成長的主要因素。根據國際糖尿病聯盟（IDF）的最新數據，2022年全球約有5.37億成年人患有糖尿病，預計2045年將達到7.83億人。糖尿病對中低收入國家的影響尤其嚴重，每年導致超過120萬人死亡。隨著全球糖尿病患者人數的增加和健康意識的提高，高效的血糖監測和疾病管理變得日益重要。

然而，這個市場也面臨許多挑戰。醫護人員持續接受先進設備操作訓練並將其融入治療方案的成本，是導致價格高昂的主要原因之一。此外，政府透過報銷機制提供的有限干預，也進一步阻礙了糖尿病患者負擔的減輕。儘管這項技術具有革新糖尿病管理的潛力，但必須先克服價格壁壘，才能使其益處惠及大眾。除非開發出更經濟實惠、更容易取得的替代方案，否則高昂的價格將繼續限制市場擴張，尤其是在發展中地區。

儘管面臨這些挑戰，市場仍蘊藏著許多成長機會。新型穿戴和微創技術的開發可望徹底改變糖尿病監測方式。早期實例包括無需指尖採血且可連續佩戴長達14天的連續血糖監測系統。此外，能夠以幾乎無痛或無負擔的方式採集組織間液的貼片式感測器也正在進行試驗。如果這些解決方案價格親民且廣泛普及，將有助於將糖尿病管理方式從不規律的自我監測轉變為近乎持續的自動化監測。這將使糖尿病患者能夠根據準確的資訊及時採取干涉措施，從而更好地控制病情。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並說明了該市場極具吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球糖尿病監測設備市場的主要參與者進行了分析：公司亮點、產品系列、主要特點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
這份全球糖尿病監測設備市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
透過對全球糖尿病監測設備市場進行分析時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第8章競爭情勢

公司簡介
- i-SENS, Inc.
- Ascensia Diabetes Care Holdings AG.
- Bayer AG
- Hoffmann-La Roche Ltd
- Johnson & Johnson Services, Inc.
- Medtronic
- Dexcom
- Abbott
- Labiotech UG
- ARKRAY, Inc.
- Cnoga
- Sanofi
- Lifescan
- Analysts'Views

第9章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI1278

Diabetes Monitoring Devices Market is estimated to be valued at USD 14.66 Bn in 2026 and is expected to reach USD 26.12 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 14.66 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.60%	2033 Value Projection:	USD 26.12 Bn

Blood glucose monitors are used by diabetic patients and clinicians to monitor and to help control a patient's blood glucose level. Most of these devices are used by patients outside the hospital setting. Many of these patients are elderly, with limited manual dexterity and impaired vision. Blood glucose monitors have a reading port into which patients place a small calibrated test strip, onto which they have applied blood, for analysis. In order to accommodate users with limited manual dexterity, the test strips cannot be too small by making the strip difficult for the user to handle.

Market Dynamics

Growing prevalence of diabetes across the globe is a major factor driving the growth of diabetes monitoring devices market. According to the latest data by the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2022 which is projected to rise to 783 million by 2045. Diabetes disproportionately affects lower and middle-income countries and accounts for over 1.2 million deaths each year. With the rising diabetic population worldwide and increasing health awareness, there is greater emphasis on efficient glucose monitoring and management of the disease.

However, the market also faces certain challenges. The costs involved in continuous training of healthcare providers to operate and integrate advanced devices into treatment plans also contribute to higher prices. Limited government intervention through reimbursement schemes further restrains affordability of diabetic patients. While technology holds promise to revolutionize diabetes management, its benefits can only percolate to masses if pricing obstacles are addressed. Unless alternatives are developed to make innovation more affordable and accessible, high prices will continue limiting market expansion especially in less developed regions.

Despite these challenges, the market presents several opportunities for growth. The development of novel wearable and minimally-invasive technologies is expected to transform diabetes monitoring. A few early examples include continuous glucose monitoring systems that do not require finger pricks and can be worn for up to 14 days. Patch-like sensors have also been trialed that extract interstitial fluid with little pain or hassle. If such solutions become widely accessible in an affordable way, they may help shift management from inconsistent self-tracking to near-constant automated oversight. This could help diabetics better control their condition through informed timely interventions.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global diabetes monitoring devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include i-SENS, Inc., Ascensia Diabetes Care Holdings AG., Bayer AG, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Medtronic, Dexcom, Abbott, Labiotech UG, ARKRAY, Inc., Cnoga, Sanofi, and Lifescan
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global diabetes monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetes monitoring devices market

Market Segmentation

By Product Type (Revenue, USD Bn, 2021 - 2033)
Self-Monitoring Blood Glucose Devices
Continuous Glucose Monitoring Devices
By Indication (Revenue, USD Bn, 2021 - 2033)
Type-I Diabetes
Type-II Diabetes
Gestational Diabetes
By End User (Revenue, USD Bn, 2021 - 2033)
Hospitals
Clinics
Ambulatory Surgical Center
Home Care Settings
Others
By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Top Companies in the Global Diabetes Monitoring Devices Market:
i-SENS, Inc.
Ascensia Diabetes Care Holdings AG.
Bayer AG
Hoffmann-La Roche Ltd
Johnson & Johnson Services, Inc.
Medtronic
Dexcom
Abbott
Labiotech UG
ARKRAY, Inc.
Cnoga
Sanofi
Lifescan

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Indication
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing prevalence of diabetes
- Technological advancements in devices
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions and Collaborations

4. Global Diabetes Monitoring Devices Market, By Product Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Self-Monitoring Blood Glucose Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Continuous Glucose Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

5. Global Diabetes Monitoring Devices Market, By Indication, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Type-I Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Type-II Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Gestational Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

6. Global Diabetes Monitoring Devices Market, By End User, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn )
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Ambulatory Surgical Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

7. Global Diabetes Monitoring Devices Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Company Profiles
- i-SENS, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Ascensia Diabetes Care Holdings AG.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Hoffmann-La Roche Ltd
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Johnson & Johnson Services, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Medtronic
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Dexcom
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Abbott
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Labiotech UG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- ARKRAY, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Cnoga
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Lifescan
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Analysts' Views